November 18, 2026
Health news, explained with evidence
LIVE

U.S. Deaths Linked to Obesity-Related Cancers More Than Double Since 1990

🏥 Public Health 2 min read 👁 2

A new analysis indicates that cancer deaths associated with a high body mass index have surged significantly over the last three decades, outpacing population growth.

U.S. Deaths Linked to Obesity-Related Cancers More Than Double Since 1990🏥Public Health

Photo: medpagetoday.com

Key points

  • Cancer deaths linked to high BMI increased by over 104% since 1990.
  • Liver, pancreatic, and uterine cancers experienced the fastest growth in mortality.
  • The burden of disease is rising significantly in Southern U.S. states.
  • Researchers emphasize the need for obesity prevention as a core component of cancer strategy.

New data presented at the ObesityWeek annual meeting reveals that deaths linked to a body mass index (BMI) of 25 or higher have increased by more than 100% since 1990. According to findings from the Global Burden of Disease 2023 study, these fatalities rose from 23,236 in 1990 to 47,450 in 2023. Researchers noted that the age-standardized death rate also climbed by 8.1%, suggesting that the trend is driven by more than just an aging or growing population.

While colorectal cancer remains the leading cause of death among this group, liver, pancreatic, and uterine cancers saw the most dramatic growth in mortality over the study period. The research also highlighted a significant rise in disability-adjusted life years, which nearly doubled to 1.11 million. Adults between the ages of 55 and 79 currently bear the largest portion of this burden, though concerning increases in uterine cancer were observed among younger women aged 15 to 39.

Geographic disparities were also evident, with the highest mortality rates concentrated in Southern states such as West Virginia, Kentucky, and Mississippi. Experts suggest that these findings underscore the need for region-specific cancer prevention strategies and a broader integration of obesity management into oncology care. Future studies are expected to evaluate how emerging treatments, such as GLP-1 medications, might influence these trends over the coming decades.

What to know: This study highlights a strong correlation between high BMI and mortality from specific cancers. Please consult your physician to discuss your personal health risks and appropriate screening schedules.

Source medpagetoday.com — medpagetoday.com/meetingcoverage/obesityweek/123914 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.